Login to Your Account



Cannabinoid drug developer Inmed sets sights on partners

By Michael Fitzhugh
Staff Writer

Friday, April 10, 2015

Inmed Pharmaceuticals Ltd., a Canadian-listed start-up mixing cannabinoids and noncannabis elements for the treatment of glaucoma is working to move into the clinic this year and attract the kind of big pharma backers that have rallied to support cannabinoid drugmaker GW Pharmaceuticals plc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription